Exosome Diagnostics, Inc. — Form D

Exosome Diagnostics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2012-08-23. The offering totals $4.0M, of which $3.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (19)

NameRoleLocation
John BoyceDirectorNew York, NY
John BoyceExecutive OfficerNew York, NY
William KellyExecutive OfficerNew York, NY
Sara BarringtonExecutive OfficerWestlake Village, CA
James McCulloughDirectorNew York, NY
James McCulloughExecutive OfficerNew York, NY
David OkronglyExecutive OfficerNew York, NY
Peter JohannDirectorNew York, NY
Joseph SlatteryDirectorWaltham, MA
Thomas McLainDirectorWaltham, MA
Thomas McLainExecutive OfficerWaltham, MA
Kapil DhingraDirectorNew York, NY
Steven SoignetDirectorWaltham, MA
Geert-Jan HC MulderDirectorWaltham, MA
Joseph BoystakDirectorNew York, NY
Dhingra KapilDirectorNew York, NY
Wayne ComperExecutive OfficerNew York, NY
Georg NebgenDirectorNew York, NY
Greg ZdechlikExecutive OfficerNew York, NY

Other filings by this issuer (8)

FiledFormOfferingSold
2017-07-06D$30.3M$30.3M
2015-09-15D$15.5M
2015-07-06D$2.2M$1.5M
2014-03-13D$40.0M$27.1M
2013-08-15D/A$8.5M$7.0M
2013-06-11D/A$8.0M$6.5M
2013-02-04D/A$6.0M$5.0M
2010-05-12D$22.5M$9.5M

More